MAXILENE®

MaxioCel Solution MS100 is a chitosan-based hemostatic wound dressing for control of moderate to severe bleeding in vascular access and trauma applications. FDA 510(k) cleared for temporary external hemorrhage management and acute wound treatment, with proven clinical use across Europe for over 5 years.

MaxioCel MX4545 is a chitosan-based hemostatic wound dressing designed for rapid bleeding control in acute and chronic wounds. FDA 510(k) cleared, it is indicated for temporary external hemorrhage management and local wound care in vascular access and trauma applications. The dressing functions as an absorbable hemostat for both internal and external bleeding scenarios.

MaxioCel MX1515 is a chitosan-based hemostatic wound dressing for controlling bleeding in vascular access sites and trauma wounds. FDA 510(k) cleared for temporary external hemorrhage management and acute/chronic wound treatment. The dressing provides rapid hemostasis for moderate to severe bleeding, lacerations, and abrasions in clinical and emergency settings.

MaxioCel MX2030 is a chitosan-based wound dressing for control of moderate to severe bleeding in acute and chronic wounds. FDA 510(k) cleared and CE marked, it provides hemostatic control for vascular access sites, trauma wounds, lacerations, and abrasions in clinical and emergency settings.

MaxioCel MX2530 is a chitosan-based hemostatic wound dressing designed for control of moderate to severe bleeding and management of external wounds including lacerations and abrasions. FDA 510(k) cleared and indicated for both acute trauma and chronic wound care applications in clinical and over-the-counter settings.

MaxioCel MX1010 is a chitosan-based hemostatic wound dressing designed for bleeding control in vascular access and trauma applications. FDA 510(k) cleared, it provides rapid hemostasis for moderate to severe bleeding, external lacerations, and abrasions in both acute and chronic wound management settings.

MaxioCel MX0505 is a chitosan-based wound care dressing for management of chronic and acute wounds, including moderate to severe bleeding control and external abrasions. FDA 510(k) cleared and CE marked, it provides hemostatic control for vascular access sites and trauma wounds in clinical and emergency settings.

MaxioCel MX0510 is a chitosan-based wound care dressing for managing chronic and acute wounds, minor cuts, lacerations, and abrasions. FDA 510(k) cleared and CE marked, it provides hemostatic control for external bleeding and wound management across clinical and over-the-counter applications.

Advanced wound care dressing combining chitosan gauze technology for rapid hemostasis and trauma management. Designed for bleeding control in acute wound care, surgical, and emergency settings. Provides biocompatible, absorbent wound coverage with hemostatic properties to support faster clotting.

MaxioCel Wound Gel MG50 is a chitosan-based wound dressing for management of acute and chronic wounds. FDA 510(k) cleared and CE marked, it provides hemostatic and absorptive properties for bleeding control and wound healing across trauma, vascular access, and general wound care applications.

Maxipore Wound Dressing is an advanced wound care solution designed for managing acute and chronic wounds across various clinical settings. The dressing provides optimal moisture balance, promotes faster healing, and maintains a protective barrier against contamination. Suitable for post-operative wounds, ulcers, and traumatic injuries in hospitals, clinics, and home care environments.

A series of Class II medical hemostatic materials designed to control bleeding during surgical procedures. These products are used to achieve hemostasis in surgical and emergency medical applications.